Alignment Healthcare Plunges 23% as Key Medicare Plan Loses 4-Star Rating
ALHC sits 19% above its 52-week low of $6.01.
Summary
Alignment Healthcare's largest Medicare Advantage contract, California H3815 HMO, fell to 3.5 stars for 2027 from 4.0 stars, threatening fiscal 2028 quality bonus payments. The contract holds over 75% of the company's members, making the downgrade highly material. Shares dropped 22.73% to $6.73 in premarket trading, hitting a new 52-week low. William Blair analyst Ryan Daniels expects continued pressure on the stock. The company disputes the rating and plans to pursue administrative remedies and litigation, but the market is pricing in the lost bonus revenue now.
At the time of this announcement, ALHC was trading at $7.15 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $6.01 to $25.12. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Benzinga.